HYFTOR vs IBRANCE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. HYFTOR and IBRANCE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	HYFTOR	IBRANCE
Rating	New	64/100
Pharmacy pays	~$48.61 /30	—
Type	RX	RX
Active ingredient	SIROLIMUS	PALBOCICLIB
Manufacturer	Nobelpharma	Pfizer
Dosage forms	Topical	Capsule, Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms	Breast Neoplasms

hyftor ibrance

Rating

New

64/100

Pharmacy pays

~$48.61 /30

—

Type

Active ingredient

SIROLIMUS

PALBOCICLIB

Manufacturer

Nobelpharma

Pfizer

Dosage forms

Topical

Capsule, Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Breast Neoplasms

Frequently asked questions

What is the difference between Hyftor and Ibrance?

Hyftor contains Sirolimus, while Ibrance contains Palbociclib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.